Beurs gesloten -
Nasdaq
22:00:00 07-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
8,79
USD
|
-1,68%
|
|
+12,40%
|
-10,85%
|
Fiscaal tijdperk: december |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
2.895
|
1.461
|
2.136
|
2.092
|
-
|
-
|
Bedrijfswaarde
1 |
2.379
|
918,1
|
1.745
|
1.770
|
1.813
|
1.820
|
K/w-verhouding
|
-11,5
x
|
-5,67
x
|
-6,24
x
|
-5,17
x
|
-4,68
x
|
-7,12
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
284
x
|
36,7
x
|
47,9
x
|
38,8
x
|
34,5
x
|
13,8
x
|
Bedrijfswaarde/omzet
|
234
x
|
23
x
|
39,2
x
|
32,8
x
|
29,9
x
|
12
x
|
Bedrijfswaarde/EBITDA
|
-13,6
x
|
-3,92
x
|
-5,36
x
|
-4,33
x
|
-3,58
x
|
-3,65
x
|
Bedrijfswaarde/FCF
|
-12
x
|
-7,61
x
|
-5,82
x
|
-4,69
x
|
-4,38
x
|
-6,71
x
|
FCF Yield
|
-8,34%
|
-13,1%
|
-17,2%
|
-21,3%
|
-22,8%
|
-14,9%
|
Price to Book
|
5,37
x
|
2,79
x
|
4,97
x
|
6,26
x
|
9,72
x
|
13,7
x
|
Aantal aandelen (in duizenden)
|
168.993
|
189.556
|
216.623
|
237.983
|
-
|
-
|
Referentieprijs
2 |
17,13
|
7,710
|
9,860
|
8,790
|
8,790
|
8,790
|
Datum van publicatie
|
23/03/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
3,962
|
10,18
|
39,84
|
44,58
|
53,92
|
60,67
|
151,4
|
EBITDA
1 |
-
|
-174,4
|
-234
|
-325,7
|
-408,5
|
-506,1
|
-499
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-182,8
|
-245,7
|
-350,1
|
-425,2
|
-506,3
|
-467,2
|
Operationele Marge
|
-
|
-1.795,79%
|
-616,74%
|
-785,33%
|
-788,59%
|
-834,61%
|
-308,5%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-186,5
|
-239,5
|
-332,1
|
-438
|
-533
|
-398
|
Nettowinst (verlies)
1 |
-87,01
|
-186,5
|
-239,5
|
-328,1
|
-410,5
|
-481,2
|
-398
|
Nettomarge
|
-2.196,01%
|
-1.832,18%
|
-601,05%
|
-735,99%
|
-761,41%
|
-793,21%
|
-262,8%
|
WPA
2 |
-5,990
|
-1,490
|
-1,360
|
-1,580
|
-1,699
|
-1,877
|
-1,234
|
Free Cash Flow
1 |
-
|
-198,4
|
-120,6
|
-299,7
|
-377
|
-414
|
-271
|
FCF-marge
|
-
|
-1.949,42%
|
-302,65%
|
-672,43%
|
-699,2%
|
-682,41%
|
-178,95%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/03/21
|
23/03/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
2,534
|
2,533
|
5,333
|
7,674
|
13,16
|
13,68
|
12,13
|
11,02
|
10,53
|
10,89
|
13,07
|
13,58
|
14,17
|
14,35
|
13,5
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-59,58
|
-
|
-66,14
|
-76,17
|
-
|
-91,38
|
-91,3
|
-91,3
|
-89,8
|
-184,8
|
-201,4
|
Bedrijfsresultaat (EBIT)
1 |
-46,4
|
-64,96
|
-55,98
|
-66,19
|
-62,57
|
-60,98
|
-69,86
|
-81,72
|
-99,55
|
-98,93
|
-100,1
|
-101,6
|
-103
|
-130,7
|
-154,8
|
Operationele Marge
|
-1.831,18%
|
-2.564,55%
|
-1.049,71%
|
-862,54%
|
-475,48%
|
-445,91%
|
-575,78%
|
-741,72%
|
-945,12%
|
-908,36%
|
-765,83%
|
-747,86%
|
-726,77%
|
-910,8%
|
-1.146,3%
|
Resultaat voor belastingen (EBT)
1 |
-47,43
|
-64,93
|
-
|
-65,56
|
-60,44
|
-57,49
|
-65,33
|
-76,73
|
-93,02
|
-94,62
|
-106
|
-106
|
-108
|
-117
|
-
|
Nettowinst (verlies)
1 |
-47,43
|
-64,93
|
-55,98
|
-65,56
|
-60,44
|
-57,49
|
-65,33
|
-76,73
|
-93,02
|
-93
|
-98,92
|
-99,42
|
-99,68
|
-126
|
-154,8
|
Nettomarge
|
-1.871,67%
|
-2.563,48%
|
-1.049,67%
|
-854,31%
|
-459,31%
|
-420,39%
|
-538,38%
|
-696,43%
|
-883,1%
|
-853,88%
|
-757,08%
|
-731,96%
|
-703,59%
|
-878,4%
|
-1.146,3%
|
WPA
2 |
-0,2800
|
-0,3800
|
-0,3300
|
-0,3800
|
-0,3500
|
-0,3000
|
-0,3400
|
-0,3800
|
-0,4300
|
-0,4200
|
-0,4160
|
-0,4133
|
-0,4085
|
-0,4836
|
-0,6750
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/11/21
|
23/03/22
|
10/05/22
|
9/08/22
|
8/11/22
|
27/02/23
|
8/05/23
|
8/08/23
|
9/11/23
|
27/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
516
|
543
|
390
|
322
|
279
|
272
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-198
|
-121
|
-300
|
-377
|
-414
|
-271
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-111%
|
-46,6%
|
-69,1%
|
-98,9%
|
-157%
|
-205%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-41%
|
-36,5%
|
-48,4%
|
-75,2%
|
-114%
|
-98,3%
|
Totale activa
1 |
-
|
454,5
|
655,8
|
677,5
|
546,2
|
421,4
|
404,7
|
Nettoactief per aandeel
2 |
-
|
3,190
|
2,770
|
1,980
|
1,400
|
0,9000
|
0,6400
|
Cashflow per aandeel
2 |
-
|
-1,270
|
-0,4800
|
-1,380
|
-0,9900
|
-0,5800
|
-
|
Capex
1 |
-
|
39,8
|
37,1
|
12
|
13
|
14
|
16
|
Capex/omzet
|
-
|
391,02%
|
93,01%
|
26,82%
|
24,11%
|
23,08%
|
10,57%
|
Datum van publicatie
|
3/03/21
|
23/03/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
8,79
USD Gemiddelde koersdoel
13
USD Spread / Gemiddelde doel +47,90% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,85% | 2,13 mld. | | +10,44% | 106 mld. | | +0,82% | 104 mld. | | +6,72% | 23,25 mld. | | -13,89% | 22,5 mld. | | -6,64% | 18,7 mld. | | -37,26% | 17,95 mld. | | -10,98% | 16,99 mld. | | +8,67% | 14,26 mld. | | +41,08% | 12,76 mld. |
Biotherapeutische geneesmiddelen
|